150 related articles for article (PubMed ID: 35860003)
1. Cantharidin Inhibits Proliferation of Liver Cancer by Inducing DNA Damage via KDM4A-Dependent Histone H3K36 Demethylation.
Wei C; Deng X; Gao S; Wan X; Chen J
Evid Based Complement Alternat Med; 2022; 2022():2197071. PubMed ID: 35860003
[TBL] [Abstract][Full Text] [Related]
2. Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation.
Ding G; Xu X; Li D; Chen Y; Wang W; Ping D; Jia S; Cao L
Cell Death Dis; 2020 Oct; 11(10):893. PubMed ID: 33093461
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Cantharidin Inhibits Proliferation of Liver Cancer by Inducing DNA Damage via KDM4A-Dependent Histone H3K36 Demethylation.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9785474. PubMed ID: 38125128
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.
Chen T; Liu R; Niu Y; Mo H; Wang H; Lu Y; Wang L; Sun L; Wang Y; Tu K; Liu Q
Cell Death Dis; 2021 Dec; 12(12):1152. PubMed ID: 34903711
[TBL] [Abstract][Full Text] [Related]
5. CTCF-KDM4A complex correlates with histone modifications that negatively regulate
Guerra-Calderas L; González-Barrios R; Patiño CC; Alcaraz N; Salgado-Albarrán M; de León DC; Hernández CC; Sánchez-Pérez Y; Maldonado-Martínez HA; De la Rosa-Velazquez IA; Vargas-Romero F; Herrera LA; García-Carrancá A; Soto-Reyes E
Oncotarget; 2018 Mar; 9(24):17028-17042. PubMed ID: 29682202
[TBL] [Abstract][Full Text] [Related]
6. Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.
Zhu M; Shi X; Gong Z; Su Q; Yu R; Wang B; Yang T; Dai B; Zhan Y; Zhang D; Zhang Y
Pharmacol Res; 2020 Aug; 158():104868. PubMed ID: 32407961
[TBL] [Abstract][Full Text] [Related]
7. Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response.
Yan J; Deng XL; Ma SQ; Hui Li Y; Gao YM; Shi GT; Wang HS
BMC Complement Med Ther; 2023 May; 23(1):160. PubMed ID: 37202806
[TBL] [Abstract][Full Text] [Related]
8. E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA.
Shen HM; Zhang D; Xiao P; Qu B; Sun YF
Cancer Gene Ther; 2023 Jul; 30(7):1007-1017. PubMed ID: 36973424
[TBL] [Abstract][Full Text] [Related]
9. Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation.
Hong M; Li J; Li S; M Almutairi M
Cells; 2019 Nov; 8(11):. PubMed ID: 31752383
[TBL] [Abstract][Full Text] [Related]
10. Cantharidin inhibits cell proliferation and induces apoptosis through G2/M phase cell cycle arrest in hepatocellular carcinoma stem cells.
Le AP; Zhang LL; Liu W; Shi YF
Oncol Rep; 2016 May; 35(5):2970-6. PubMed ID: 26986084
[TBL] [Abstract][Full Text] [Related]
11. RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.
Chen DB; Xie XW; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Fei R; Qin WY; Wang JH; Wu X; Shao QX; Wei L; Chen HS
Sci Rep; 2020 Sep; 10(1):14538. PubMed ID: 32883983
[TBL] [Abstract][Full Text] [Related]
12. Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2/Bax.
Tian X; Zeng G; Li X; Wu Z; Wang L
Oncol Rep; 2015 Jun; 33(6):3061-8. PubMed ID: 25962755
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
14. Cantharidin alters the expression of genes associated with the NKG2D-associated immune response in TSGH-8301 human bladder carcinoma cells.
Kuo JH; Huang AC; Lin JJ; Lai KC; Wu RS; Yang JL; Ji BC; Yang MD; Chu YL; Chung JG
Oncol Lett; 2017 Jul; 14(1):234-240. PubMed ID: 28693159
[TBL] [Abstract][Full Text] [Related]
15. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
[TBL] [Abstract][Full Text] [Related]
16. The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
Xu MD; Liu SL; Zheng BB; Wu J; Wu MY; Zhang Y; Gong FR; Tao M; Zhang J; Li W
Pancreatology; 2018 Oct; 18(7):822-832. PubMed ID: 30201439
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis and proliferation of human hepatocellular carcinoma.
Hino N; Higashi T; Nouso K; Nakatsukasa H; Tsuji T
Liver; 1996 Apr; 16(2):123-9. PubMed ID: 8740846
[TBL] [Abstract][Full Text] [Related]
18. KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma.
Chen M; Jiang Y; Sun Y
Biochem Biophys Res Commun; 2021 Apr; 550():77-83. PubMed ID: 33689883
[TBL] [Abstract][Full Text] [Related]
19. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification.
Li S; Hao L; Hu X; Li L
Infect Agent Cancer; 2023 Jul; 18(1):41. PubMed ID: 37393234
[TBL] [Abstract][Full Text] [Related]
20. Circ_SPECC1 enhances the inhibition of miR-526b on downstream KDM4A/YAP1 pathway to regulate the growth and invasion of gastric cancer cells.
Chen LH; Wang LP; Ma XQ
Biochem Biophys Res Commun; 2019 Sep; 517(2):253-259. PubMed ID: 31349968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
